| Literature DB >> 29698410 |
Yan Yang1,2, Yan Ni Yan1, Ya Xing Wang3, Jie Xu3, Jie Ren2, Liang Xu3, Jost B Jonas3,4, Wen Bin Wei1.
Abstract
PURPOSE: To assess the 10-year incidence and progression of epiretinal membranes (ERMs).Entities:
Mesh:
Year: 2018 PMID: 29698410 PMCID: PMC5919611 DOI: 10.1371/journal.pone.0195768
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Fig 1A: Right eye of 55-year-old man with early preretinal macular fibrosis superior to the fovea at baseline in 2001. Fig 1B: After 10 years, the area of preretinal macular fibrosis is enlarged.
Fig 2Fig 2A: Left eye of a 47-year-old woman with early preretinal macular fibrosis superior to the fovea macula at baseline in 2001. Fig 2B: After 10 years, the preretinal macular fibrosis disappeared.
Fig 3Fig 3A: Left eye of a 76-year-old man with preretinal macular fibrosis at the baseline examination in 2011. Fig 3B: After 10 years, the preretinal macular fibrosis transformed to cellophane macular reflex, with cataract surgery performed in 2006.
Fig 4Fig 4A: Left eye of a 69-year-old woman with preretinal macular fibrosis at the baseline examination in 2001. Fig 4B: After 10 years, the epiretinal membrane remained unchanged.
Study population and 10-year incidence of epiretinal membranes, stratified by age and gender, in the Beijing Eye Study 2001/2011.
| Age Group (Years) | Gender | All Study Particpants | |||||
|---|---|---|---|---|---|---|---|
| Type of Epiretinal Membrane | <60 | 60–69 | 70–79 | >80 | Women | Men | |
| (n = 972) | (n = 777) | (n = 589) | (n = 138) | (n = 1418) | (n = 1058) | (n = 2476) | |
| Cellophane Macular reflex | 21 | 55 | 59 | 12 | 94 | 53 | 147 |
| Preretinal Macular Fibrosis | 9 | 23 | 26 | 3 | 35 | 26 | 61 |
| Total | 30 (3.1%) | 78 (10.0%) | 85 (14.4%) | 15 (10.9%) | 129 (9.1%) | 79 (7.5%) | 208 (8.4%) |
Associations (univariate analysis) between the ten-year incidence of epiretinal membranes and ocular and systemic parameters in the Beijing Eye Study 2001/2011.
| Parameter | Odds Ratio | 95% Confidence Interval | |
|---|---|---|---|
| General Parameters | |||
| Age (Years) | <0.001 | 1.06 | 1.05–1.08 |
| Gender (Men / Women) | 0.15 | 1.24 | 0.93–1.66 |
| Rural / Urban Region of Habitation | 0.007 | 1.49 | 1.11–1.98 |
| Education (High school and Higher) | 0.62 | 1.02 | 0.94–1.10 |
| Cognitive Score | 0.65 | 1.01 | 0.97–1.06 |
| Body Height (cm) | 0.04 | 0.98 | 0.96–1.00 |
| Body Weight (kg) | 0.09 | 0.99 | 0.98–1.00 |
| Waist Circumference (cm) | 0.50 | 1.00 | 0.99–1.02 |
| Systolic Blood pressure (mmHg) | 0.40 | 1.00 | 0.99–1.01 |
| Diastolic Blood pressure (mmHg) | 0.01 | 0.99 | 0.97–1.00 |
| Hyperlipidemia | 0.12 | 0.97 | 0.93–1.01 |
| Arterial Hypertension | 0.11 | 1.28 | 0.94–1.73 |
| Diabetes | 0.11 | 1.41 | 0.93–2.13 |
| History of Cardiovascular Disease | 0.43 | 1.16 | 0.80–1.70 |
| History of Cerebral Infarction | 0.28 | 1.35 | 0.79–2.32 |
| Aspirin Intake | 0.03 | 1.40 | 1.04–1.90 |
| Smoking | 0.19 | 0.80 | 0.57–1.12 |
| Body Mass Index >25.00 kg/m2 | 0.27 | 0.85 | 0.63–1.14 |
| Glycosylated Hemoglobin HbA1c (%) | 0.81 | 0.97 | 0.79–1.21 |
| Serum Concentration of Glucose (mmol/L) | 0.14 | 0.88 | 0.75–1.04 |
| Serum Concentration of Creatinine (μmol/L) | 0.79 | 1.00 | 0.99–1.01 |
| Serum Concentration of Cholesterol (mmol/L) | 0.12 | 1.13 | 0.97–1.33 |
| Serum Concentration of High-Density Lipoproteins (mmol/L) | 0.19 | 1.27 | 0.89–1.80 |
| Serum Concentration of Low-Density Lipoproteins (mmol/L) | 0.12 | 1.17 | 0.96–1.41 |
| Serum Concentration of Triglycerides (mmol/L) | 0.70 | 0.98 | 0.88–1.09 |
| C-Reactive Protein | 0.26 | 0.95 | 0.88–1.04 |
| Ocular Parameters | |||
| Best Corrected Visual Acuity (logMAR) | <0.001 | 0.39 | 0.24–0.64 |
| Refractive Error (Diopters) | 0.46 | 1.03 | 0.95–1.11 |
| Intraocular Pressure (mmHg) | 0.03 | 0.94 | 0.89–0.99 |
| Axial Length (mm) | 0.37 | 1.06 | 0.93–1.20 |
| Anterior Chamber Depth (mm) | 0.03 | 1.36 | 1.04–1.78 |
| Cornea Thickness (μm) | 0.21 | 1.00 | 1.00–1.01 |
| Subfoveal Choroidal Thickness (<250um) | 0.05 | 1.40 | 1.00–1.80 |
| Cataract Surgery | <0.001 | 3.94 | 2.54–6.12 |
| Arcus Senilis | <0.001 | 1.44 | 1.22–1.69 |
| Retinal Vein Oclussion | 0.07 | 1.92 | 0.94–3.94 |
| Retinal Neural Fiber Layer Defects | 0.54 | 1.17 | 0.71–1.90 |
| Complete Posterior Vitreous Detachment (Detected by Optical Coherence Tomography) | <0.001 | 2.52 | 1.69–3.74 |
| Glaucoma | 0.27 | 1.37 | 0.78, 2.38 |
| Open-Angle Glaucoma | 0.20 | 1.59 | 0.78, 3.25 |
| Angle-Closure Glaucoma | 0.81 | 0.84 | 0.20, 3.57 |
| Age-Related Macular Degeneration, Any Stage | 0.12 | 1.28 | 0.94, 1.74 |
| Age-Related Macular Degeneration, Early Stage | 0.18 | 1.37 | 0.86, 2.19 |
| Age-Related Macular Degeneration, Intermediate Stage | 0.43 | 1.16 | 0.80, 1.67 |
| Age-Related Macular Degeneration, Late Stage | 0.67 | 0.67 | 0.10, 4.33 |
| Diabetic Retinopathy, Prevalence | 0.46 | 1.39 | 0.59, 3.28 |
| Diabetic Retinopathy, Stage | 0.56 | 1.13 | 0.76, 1.67 |
| Cataract, Nuclear | 0.002 | 1.70 | 1.21, 2.38 |
| Cataract, Cortical | 0.66 | 1.11 | 0.71, 1.73 |
| Cataracta, Subcapsular Posterior | 0.22 | 0.48 | 0.15, 1.55 |
Associations (multivariate analysis) of the ten-year incidence of epiretinal membranes in the Beijing Eye Study 2001/2011.
| Parameter | Odds Ratio | 95% Confidence Interval | |
|---|---|---|---|
| Age (Years) | <0.001 | 1.06 | 1.04–1.09 |
| Age Group (60–69 years old) | <0.001 | 2.87 | 1.76–4.67 |
| Age Group (70–79 years old) | <0.001 | 4.02 | 2.25–7.18 |
| Cataract Surgery | 0.003 | 3.32 | 1.51–7.29 |
| Complete Posterior Vitreous Detachment | 0.02 | 1.84 | 1.12–3.02 |
Change in epiretinal membranes in eyes with pre-existing epiretinal membranes during a 10-year follow-up in the Beijing Eye Study 2001/2011.
| Type of Epiretinal Membrane at Baseline | |||
|---|---|---|---|
| Change during 10-Year Period | Preretinal Macular Fibrosis | Cellophane Macular Reflex | Any |
| Progressed | 14 (38.9%) | 6 (21.4%) | 20 (31.3%) |
| Stable | 10 (27.8%) | 10 (35.7%) | 20 (31.3%) |
| Regressed | 12 (33.3%) | 12 (42.9%) | 24 (37.5%) |